Upcoming Courses
27th Annual Summer Seminars: Alcohol and Substance Abuse Treatment
Roger Weiss, MD
Substance use disorders are common in both general psychiatric and medical practice. Because clinicians often do not have the knowledge about how to treat these disorders, it is common for clinicians to not screen for them. This often leads to poor outcomes for these patients. This course will review key issues that clinicians need to know about the diagnosis and treatment of patients with alcohol and drug abuse problems. The course will consist of lecture and audience interaction, including discussion of cases. The course will review diagnosis, pharmacologic and behavioral treatment strategies, treatment of patients with co-occurring psychiatric illness, a review of the common drugs of abuse, including prescription drug abuse, recent trends in drug abuse, and strategies to help family members of those with substance use disorders.
- Diagnose substance use disorders;
- Determine options for abstinence vs. cutting down;
- Evaluate indications for and use of common substance
use disorder medications; - Distinguish substance-induced disorders vs. independent
psychiatric illness; - Refer patients knowledgeably to mutual-help groups
such as AA or SMART Recovery; - Discuss key properties of the common drugs of abuse;
- Describe the clinical implications of legalized medical and recreational marijuana and develop effective clinical responses;
- Develop helpful strategies for family members of those with substance use disorders;
- Develop helpful strategies for patients who want to cut down but whom you think should abstain;
- Analyze models of both psychopharmacological and psychotherapeutic treatments for patients with substance use disorders and co-occurring psychiatric illness.
Additional Information
|
Monday, August 22, 2016 |
|
|
8:30-9:00 AM |
Registration |
|
9:00-10:15 AM |
Making a diagnosis: changes from DSM-IV to DSM-5; Screening, diagnosing, and beginning treatment at the same time: key things to know for an effective initial interview. |
|
10:15-10:30 AM |
Continental Coffee Break |
|
10:30-12:15 PM |
Recommend abstinence or cutting down? What to do when the patient wants to cut down and you think that abstinence is the best course? |
|
Tuesday, August 23, 2016 |
|
|
9:00-10:15 AM |
The unmotivated patient: techniques to deal with denial, ambivalence, and reluctance to change. How to use motivate, persuade, and confront effectively. |
|
10:15-10:30 AM |
Continental Coffee Break |
|
10:30 AM-12:15 PM |
Key facts you need to know about the major substances of abuse: alcohol, heroin, prescription opioids, cocaine and other stimulants, hallucinogens, and marijuana; how to use medications for substance use disorders: naltrexone, disulfiram, acamprosate, buprenorphine, methadone. |
|
Wednesday, August 24, 2016 |
|
|
9:00-10:15 AM |
How to use medications for alcohol use disorders: naltrexone, disulfiram, acamprosate. |
|
10:15-10:30 AM |
Continental Coffee Break |
|
10:30 AM-12:15 PM |
Psychotherapy of substance use disorders: what works best? |
|
Thursday, August 25, 2016 |
|
|
9:00-10:15 AM |
The “dually diagnosed” patient with co-occurring psychiatric illness; distinguishing substance-induced disorders vs. independent psychiatric disorders. |
|
10:15-10:30 AM |
Continental Coffee Break |
|
10:30 AM-12:15 PM |
Integrating treatment for patients with co-occurring psychiatric illness and substance use problems: psychotherapeutic and pharmacological strategies; Q&A. |
|
Friday, August 26, 2016 |
|
|
9:00-10:15 AM |
Referring patients to 12-step (e.g., AA) and non-12-step (e.g., SMART Recovery) mutual-help support groups: what you need to know. |
|
10:15-10:30 AM |
Continental Coffee Break |
|
10:30 AM-12:15 PM |
Helping family members of patients with substance use disorders. Interventions: new models. |
|
12:15 PM |
Adjourn |
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15
Accreditation:
Physicians This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of pmiCME and The Continuing Education Program at Beth Israel Deaconess Medical Center. pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION:
Weeklong Seminar: pmiCME designates the live activity for a maximum of 15 AMA PRA Category 1 Credits™
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits(ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 15 ECMEC© Credits are available. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Psychologists The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School maintains responsibility for this program and its content.
Counselors The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5689. Programs that do not qualify for NBCC credit are clearly identified. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is solely responsible for all aspects of the programs.
Social Workers For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please call 617-754-1265 or email: sjruiz@bidmc.harvard.edu.
This program meet the specifications for the Board of Registration in Nursing (244 CMR)
– See more at: https://continuingeducationprogram.org/courses/27th-annual-summer-seminars-a-new-prescription-exercise-and-other-groundbreaking-techniques-for-the-treatment-of-adhd-aggression-and-autism-spectrum-disorder/#sthash.cYYEv3qq.dpuf
Roger Weiss, MD is a Professor of Psychiatry at Harvard Medical School and Chief of the Division of Alcohol and Drug Abuse at McLean Hospital. He is the author over 300 scientific publications including, Integrated Group Therapy for Bipolar Disorder and Substance Abuse. Dr. Weiss is on the editorial board of many journals includingAmerican Journal of Drug and Alcohol Abuse, Journal of Clinical Psychiatry, and theAmerican Journal on Addiction.